In an unprecedented tie-up unveiled Tuesday, the companies are joining forces to work on a potential COVID-19 vaccine. They aim to start human testing in the second half of this year, and if all goes well, to file for potential approvals by the second half of 2021. FiercePharma
Tuesday, April 14, 2020
Sanofi, GSK tie up for COVID-19 vaccine work with eyes on possible 2021 rollout
In an unprecedented tie-up unveiled Tuesday, the companies are joining forces to work on a potential COVID-19 vaccine. They aim to start human testing in the second half of this year, and if all goes well, to file for potential approvals by the second half of 2021. FiercePharma
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment